July 10, 2020 / 9:16 AM / a month ago

BRIEF-Zhejiang Orient Gene Biotech Sees H1 Net Profit Surge, Boosted By Strong Demand Coronavirus Testing Kits

July 10 (Reuters) - Zhejiang Orient Gene Biotech Co Ltd :

* SAYS IT SEES H1 NET PROFIT UP 1,294.1% Y/Y AT 463.0 MILLION YUAN ($66.07 million), BOOSTED BY STRONG DEMAND OF ITS CORONAVIRUS TESTING KITS Source text in Chinese: bit.ly/2CmvRrH Further company coverage: ($1 = 7.0072 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below